About the journal
OncoImmunology is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,300 USD. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis Group
- ISSN
- 2162-4011 · 2162-402X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,300 USD
- Articles in DOAJ
- 2083
- Declared review time
- 24 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.tandfonline.com/journals/koni
Index listings
- DOAJ · 2020-05-11
- MEDLINE · 2020-01-01
- PUBMED · 2012-01-01
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,300 USD
- Declared review time (DOAJ)
- 24 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2083
Most recent article
last month
Average review time (journal-declared via DOAJ)
24weeks
Works in OpenAlex
3918
Last recorded publication year
2026
h-index
152
i10-index
2987
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2025-01-13
- Added to DOAJ
- 2020-05-11
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPorticoScholars Portal
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 78%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Oncoimmunology
- Source type
- journal
- NLM unique ID (PubMed)
- 101570526
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- CAR-T cell therapy research
Show all subjects (50)
- Immune cells in cancer
- Immune cells in cancer
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Virus-based gene therapy research
- Virus-based gene therapy research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Immune Response and Inflammation
- Immune Response and Inflammation
- Phagocytosis and Immune Regulation
- Phagocytosis and Immune Regulation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Research and Treatments
- Cancer Research and Treatments
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Chemokine receptors and signaling
- Chemokine receptors and signaling
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- interferon and immune responses
- interferon and immune responses
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer, Stress, Anesthesia, and Immune Response
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Cancer, Stress, Anesthesia, and Immune Response
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- Adenosine and Purinergic Signaling
- Adenosine and Purinergic Signaling
- Peptidase Inhibition and Analysis
- Glioma Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Glioma Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
Keywords (DOAJ)
- oncology
- immunology
- immunotherapy
- tumour immunology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ